Nymox Pharmaceutical Corporation NYMX
0.20 +0.20
Day range unavailable
52-week range unavailable
Ownership
Held by insiders 45.03%
Held by institutions 1.12%
Float held by institutions 2.03%
Institutions 39
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 0.15% | 135,612 | 27.12K | Mar 30, 2023 |
| Cetera Advisor Networks LLC | 0.13% | 118,900 | 23.78K | Mar 30, 2023 |
| Morgan Stanley | 0.11% | 98,686 | 19.74K | Mar 30, 2023 |
| Simplicity Solutions, LLC | 0.09% | 80,000 | 16.00K | Mar 30, 2023 |
| Bleakley Financial Group, LLC | 0.09% | 80,000 | 16.00K | Mar 30, 2023 |
| Renaissance Technologies, LLC | 0.08% | 69,381 | 13.88K | Mar 30, 2023 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Micro Cap ETF | 0.12% | 112,238 | 22.45K | Feb 27, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.06% | 50,678 | 10.13K | Feb 27, 2023 |
| EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 9,318 | 1.86K | Dec 30, 2022 |
| Master Investment Portfolio-Diversified Equity Master Portfolio | 0.01% | 5,685 | 1.14K | Dec 30, 2022 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AVERBACK PAUL | Chief Executive Officer | Sale | Oct 28, 2018 | 21,643,900 |
| DANIELSEN ERIK | Chief Financial Officer | Purchase | Dec 20, 2018 | 20,900 |
| LANHAM RANDALL J ESQ. | General Counsel | Purchase | Oct 25, 2018 | 152,900 |
| ROBINSON JAMES GEORGE | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 26, 2023 | 4,782,060 |